C-Jun NH2-Terminal Kinase Contributes to Dexmedetomidine-Induced Contraction in Isolated Rat Aortic Smooth Muscle

被引:17
作者
Ok, Seong-Ho [1 ]
Jeong, Young Seok [1 ]
Kim, Jae-Gak [1 ]
Lee, Seung-Min [1 ]
Sung, Hui-Jin [1 ]
Kim, Hye Jung [4 ]
Chang, Ki Churl [4 ]
Kwon, Seong-Chun [5 ]
Sohn, Ju-Tae [1 ,2 ,3 ]
机构
[1] Gyeongsang Natl Univ Hosp, Dept Anesthesiol & Pain Med, Jinju 660702, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Jinju, South Korea
[3] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea
[4] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju, South Korea
[5] Kwandong Univ, Coll Med, Dept Physiol, Kangnung, South Korea
关键词
Dexmedetomidine; mitogen-activated protein kinase; alpha(2B)-adrenoceptors; hypertension; rat aorta; ALPHA(1)-ADRENERGIC ANTAGONIST ACTIONS; DUAL ALPHA(2)-ADRENERGIC AGONIST; LIPOXYGENASE PATHWAY ACTIVATION; NITRIC-OXIDE SYNTHESIS; CORONARY HEMODYNAMICS; CALCIUM; CELLS; HYPERTENSION; MEDETOMIDINE; STIMULATION;
D O I
10.3349/ymj.2011.52.3.420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Dexmedetomidine, a full agonist of alpha(2B)-adrenoceptors, is used for analgesia and sedation in the intensive care units. Dexmedetomidine produces an initial transient hypertension due to the activation of post-junctional alpha(2B)-adrenoceptors on vascular smooth muscle cells (SMCs). The aims of this in vitro study were to identify mitogen-activated protein kinase (MAPK) isoforms that are primarily involved in full, alpha(2B)-adrenoceptor agonist, dexmedetomidine-induced contraction of isolated rat aortic SMCs. Materials and Methods: Rat thoracic aortic rings without endothelium were isolated and suspended for isometric tension recording. Cumulative dexmedetomidine (10(-9) to 10(-6) M) dose-response curves were generated in the presence or absence of extracellular signal-regulated kinase (ERIC) inhibitor PD 98059, p38 MAPK inhibitor SB 203580, c-Jun NH2-terminal kinase (JNK) inhibitor SP 600125, L-type calcium channel blocker (verapamil and nifedipine), and alpha(2)-adrenoceptor inhibitor atipamezole. Dexmedetomidine-induced phosphorylation of ERIC, JNK, and p38 MAPK in rat aortic SMCs was detected using Western blotting. Results: SP 600125 (10(-6) to 10(-5) M) attenuated dexmedetomidine-evoked contraction in a concentration-dependent manner, whereas PD 98059 had no effect on dexmedetomidine-induced contraction. SB 203580 (10(-5) M) attenuated dexmedetomidine-induced contraction. Dexmedetomidine-evoked contractions were both abolished by atipamezole and attenuated by verapamil and nifedipine. Dexmedetomidine induced phosphorylation of JNK and p38 MAPK in rat aortic SMCs, but did not induce phosphorylation of ERIC. Conclusion: Dexmedetomidine-induced contraction involves a JNK- and p38 MAPK-mediated pathway downstream of alpha(2)-adrenoceptor stimulation in rat aortic SMCs. In addition, dexmedetomidine-induced contractions are primarily dependent on calcium influx via L-type calcium channels.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [21] Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-κB-inducing kinases
    Li, LF
    Ouyang, B
    Choukroun, G
    Matyal, R
    Mascarenhas, M
    Jafari, B
    Bonventre, JV
    Force, T
    Quinn, DA
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 285 (02) : L464 - L475
  • [22] Tumor necrosis factor α-mediated activation of c-Jun NH2-terminal kinase as a mechanism for fumonisin B1 induced apoptosis in murine primary hepatocytes
    Sharma, N
    Suzuki, H
    He, QR
    Sharma, RP
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2005, 19 (06) : 359 - 367
  • [23] Activation of c-Jun NH2-terminal kinases by interleukin-1β in normal human osteoblastic and rat UMR-106 cells
    Chaudhary, LR
    Avioli, LV
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1998, 69 (01) : 87 - 93
  • [24] Histamine differentially interacts with tumor necrosis factor-α and thrombin in endothelial tissue factor induction:: the role of c-Jun NH2-terminal kinase
    Steffel, J.
    Arnet, C.
    Akhmedov, A.
    Iseli, S. M.
    Luescher, T. F.
    Tanner, F. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (11) : 2452 - 2460
  • [25] Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3
    Strittmatter, F.
    Walther, S.
    Gratzke, C.
    Goettinger, J.
    Beckmann, C.
    Roosen, A.
    Schlenker, B.
    Hedlund, P.
    Andersson, K. E.
    Stief, C. G.
    Hennenberg, M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (06) : 1926 - 1935
  • [26] Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase)
    Tournier, C
    Thomas, G
    Pierre, J
    Jacquemin, C
    Pierre, M
    Saunier, B
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (02): : 587 - 595
  • [27] Adipose c-Jun NH2-terminal kinase promotes angiotensin II-induced and deoxycorticosterone acetate salt-induced hypertension and vascular dysfunction by inhibition of adiponectin production and activation of SGK1 in mice
    Gan, Jing
    Shi, Yaru
    Zhao, Ruyi
    Li, Dan
    Jin, Hua
    Wu, Maolan
    Liu, Zhen
    Li, Xiaokun
    Xu, Aimin
    Li, Yulin
    Lin, Zhuofeng
    Wu, Fan
    JOURNAL OF HYPERTENSION, 2024, 42 (05) : 856 - 872
  • [28] Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction
    Zhong, Linmao
    Shu, Wangqin
    Dai, Wangbin
    Gao, Bo
    Xiong, Sidong
    JOURNAL OF VIROLOGY, 2017, 91 (15)
  • [29] C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis
    Zeng, Cheng
    Xu, Jia-ning
    Zhou, Yan
    Yang, Hui-xia
    Zhou, Ying-fang
    Xue, Qing
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11) : E1404 - E1414
  • [30] c-Jun NH2-terminal kinase (JNK)/stress-activated protein kinase-associated protein 1 is a critical regulator for arthritis progression by meditating inflammation in mice model
    Guo, Hao
    Lei, Hong
    Zhang, Bao-Gang
    Xu, Zhao-Chen
    Dong, Chen
    Hao, Yang-Quan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81